Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for Prevention of Microalbuminuria in Type 1 Diabetes (PREVENTKD)
NCT00729365Phase 3Terminated
- Sponsor
- Northwestern University
- Start
- Jul 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in diabetic nephropathy (DN), sponsored by Northwestern University. Started Jul 2008; status: terminated.
02
Drugs
ramipril
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00729365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729365.